Maciej Cabanski

Maciej Cabanski

Company: Monte Rosa Therapeutics

Job title: Senior Director Biomarkers & CDx


Track Chair
11:02 am

Read more

day: Conference Day Two - Track 1

Molecular Glue Degraders for Non-Oncology Indications 12:30 pm

Introducing molecular glue degraders (MGDs) as a targeted protein degradation (TPD) approach Leveraging the application of MGDs in non-oncology indications, such as diseases associated with autoimmunity and inflammation Illuminating the main utility of Biomarkers in Targeted ProteinDegradationRead more

day: Conference Day One - Track 1

Chair’s Closing Remarks & End of 14th Clinical Biomarkers & CDx Europe Summit 2024 5:30 pm

Read more

day: Conference Day Two - PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.